Nicholas Lorusso

Stock Analyst at TD Cowen

(2.26)

# 2,741

Out of 5,241 analysts

2

Total ratings

50%

Success rate

25.88%

Average return

Main Sectors:

Top Industries:

Biotechnology Drug Manufacturers - Specialty & Generic

Stocks Rated by Nicholas Lorusso

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	IMTX Immatics	Initiates: Buy	n/a	$10.87	-	1	Apr 28, 2026
	KNSA Kiniksa Pharmaceuticals International,	Initiates: Buy	$60	$56.51	+6.18%	1	Sep 29, 2025

Immatics

Apr 28, 2026

Initiates: Buy

Price Target: n/a

Current: $10.87

Upside: -

Kiniksa Pharmaceuticals International,

Sep 29, 2025

Initiates: Buy

Price Target: $60

Current: $56.51

Upside: +6.18%